Acadia Healthcare Company, Inc. (ACHC)
$
22.64
-0.21 (-0.93%)
Key metrics
Financial statements
Free cash flow per share
-0.9331
Market cap
2.4 Billion
Price to sales ratio
0.7483
Debt to equity
0.7650
Current ratio
1.3498
Income quality
2.3455
Average inventory
2.8 Million
ROE
0.0620
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States and Puerto Rico, highlighting the company's operational efficiency with an EBITDA ratio of 0.19. The company's stock is identified with the symbol 'ACHC' in the market, allowing investors to track its performance effectively. Acadia reported a substantial revenue of $3,153,963,000.00 reflecting its strong market presence and ability to cater to diverse patient needs. The income before tax ratio stands at 0.11 illustrating the pre-tax margin and underlying profitability. Moreover, the company reported selling, general, and administrative expenses of $189,706,000.00 indicating its operational overhead costs as it manages a network of facilities that includes inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, Acadia operates 238 behavioral healthcare facilities with approximately 10,600 beds, demonstrating its commitment to offering comprehensive healthcare solutions. The stock is affordable at $22.85 making it suitable for budget-conscious investors looking for entry points in the market. With a high average trading volume of 2,655,553.00 the stock indicates strong liquidity, which appeals to active traders and long-term investors alike. With a mid-range market capitalization of $2,085,646,608.00 the company is a steady performer amidst market fluctuations. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape, addressing the growing need for mental health services. Acadia Healthcare belongs to the Healthcare sector, driving innovation and growth as it advances its mission to provide quality care and improve outcomes for its patients. This essential role in the behavioral healthcare field positions it favorably for continued success and relevance in a rapidly evolving industry.
Is Acadia Healthcare Company, Inc. (ACHC) a good investment?
Investing in Acadia Healthcare Company, Inc. (ACHC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
What is Acadia Healthcare Company, Inc. (ACHC)'s stock forecast?
Analysts predict Acadia Healthcare Company, Inc. stock to fluctuate between $20.36 (low) and $82.41 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Acadia Healthcare Company, Inc.'s market capitalization?
As of 2025-05-30, Acadia Healthcare Company, Inc.'s market cap is $2,085,646,608, based on 92,122,200 outstanding shares.
How does Acadia Healthcare Company, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Acadia Healthcare Company, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Acadia Healthcare Company, Inc. (ACHC) stock?
To buy Acadia Healthcare Company, Inc. (ACHC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ACHC. Place an order (Market, Limit, etc.).
What is the best time to invest in Acadia Healthcare Company, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Acadia Healthcare Company, Inc. stock ever split?
Acadia Healthcare Company, Inc.'s last stock split was 1:4 on 2011-11-01.
How did Acadia Healthcare Company, Inc. perform in the last earnings report?
Revenue: $3,153,963,000 | EPS: $2.79 | Growth: -1,262.50%.
Where can I find Acadia Healthcare Company, Inc.'s investor relations reports?
Visit https://www.acadiahealthcare.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Acadia Healthcare Company, Inc.?
You can explore historical data from here
What is the all-time high and low for Acadia Healthcare Company, Inc. stock?
All-time high: $89.85 (2022-11-30) | All-time low: $20.36 (2025-04-21).
What are the key trends affecting Acadia Healthcare Company, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
accessnewswire.com
NEW YORK, NY / ACCESS Newswire / May 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
zacks.com
Investors need to pay close attention to ACHC stock based on the movements in the options market lately.
seekingalpha.com
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q1 2025 Results Conference Call May 13, 2025 8:30 AM ET Company Participants Brian Farley - EVP and General Counsel Chris Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Brian Tanquilut - Jefferies Whit Mayo - Leerink Partners John Ransom - Raymond James Pito Chickering - Deutsche Bank Matthew Gillmor - KeyBanc Capital Markets Andrew Mok - Barclays Joanna Gajuk - Bank of America Operator Good day, and welcome to Acadia Healthcare's First Quarter of 2025 Earnings Call.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / May 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
zacks.com
ACHC's first-quarter results are likely to reflect benefits from growing revenue per patient day.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / April 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / April 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
zacks.com
ACHC, BLKB and CABO have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2025.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
See all news
